| 1 |
Which of the following best describes the concept of "beat perception" as it relates to the auditory capabilities of newborn infants?
|
The extraction of a consistent rhythm from a sequence of sounds. |
|
"Beat perception" refers to the ability of newborn infants to identify and extract a steady rhythm or beat from a series of auditory stimuli. According to the article, there are detecting rhythm while asleep, independent of statistical learning, and core auditory skills.
|
Information from the article "Beat processing in newborn infants cannot be explained by statistical learning based on transition probabilities"
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 2 |
According to the research, what experimental method is used to differentiate beat perception from statistical learning in newborns?
|
Monitoring brain activity using EEG during auditory stimulation. |
|
The research used EEG during auditory stimulation to investigate how newborns process rhythmic patterns and differentiate beat perception from statistical learning, providing direct evidence of innate auditory capabilities.
|
Information from the article "Beat processing in newborn infants cannot be explained by statistical learning based on transition probabilities"
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 3 |
What does the mismatch response (MMR) in EEG studies indicate about newborns' auditory processing?
|
Sensitivity to regularity violations in sound sequences. |
|
Mismatch Response (MMR) is a neural marker observed in EEG studies that reflects the detection of irregularities in auditory patterns, the evidence of auditory processing in newborns, and the independent of statistical learning. Therefore, the mismatch response (MMR) indicates newborns' sensitivity to regularity violations in sound sequences, highlighting their ability to process auditory patterns and detect deviations from expected rhythms.
|
Information from the article "Beat processing in newborn infants cannot be explained by statistical learning based on transition probabilities"
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 4 |
What does the term "statistical learning" refer to in the context of auditory processing in newborns?
|
Extraction of regularities from the order of sounds without explicit feedback. |
|
In the context of auditory processing in newborns, statistical learning refers to identifying patterns and regularities, implicit learning mechanisms, and critical for language development. It involves the extraction of regularities from the order of sounds without explicit feedback.
|
Information from the article "Beat processing in newborn infants cannot be explained by statistical learning based on transition probabilities"
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 5 |
Which condition in the EEG study did NOT result in a differentiation between beat and offbeat responses in newborns?
|
Silence condition. |
|
The silence condition served as a control in which no auditory stimuli were presented. As a result, there were no beat or offbeat sounds to process, so no differentiation between beat and offbeat responses could occur.
|
Information from the article "Beat processing in newborn infants cannot be explained by statistical learning based on transition probabilities"
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 6 |
Which neural mechanism is thought to underlie the synchronization of movement to a beat?
|
Neural entrainment. |
|
Neural entrainment refers to the synchronization of neural oscillations in the brain with the rhythmic patterns of external stimuli, such as a musical beat. This mechanism is believed to underlie the ability to synchronize movement to a beat, as it aligns brain activity with external rhythms, supports predictive timing, and is foundational for rhythmic coordination.
|
Information from the article "Beat processing in newborn infants cannot be explained by statistical learning based on transition probabilities"
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 7 |
How does beat perception in newborns relate to their later musical abilities?
|
It is fundamental for developing rhythmic coordination and timing. |
|
Beat perception in newborns plays a foundational role in the development of musical and motor abilities later in life because it supports rhythmic coordination, facilitates timing skills, and is foundational for musicality.
|
Information from the article "Beat processing in newborn infants cannot be explained by statistical learning based on transition probabilities"
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 8 |
What does an isochronous condition in an auditory study typically involve?
|
A consistent temporal interval between sounds. |
|
An isochronous condition refers to a sequence of sounds presented at regular, consistent intervals, where the time between each sound remains the same. This regularity makes it easier for listeners, including newborns in auditory studies, to detect and align with a rhythmic pattern or beat.
|
Information from the article "Beat processing in newborn infants cannot be explained by statistical learning based on transition probabilities"
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 9 |
What is the primary purpose of using EEG in studies of auditory processing in newborns?
|
To record brain responses to sounds. |
|
EEG (Electroencephalography) is used to record electrical activity in the brain in response to auditory stimuli. This method is particularly effective for understanding how newborns process sounds, as it is non-invasive, safe, and capable of capturing real-time neural responses.
|
Information from the article "Beat processing in newborn infants cannot be explained by statistical learning based on transition probabilities"
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 10 |
Which auditory feature is NOT directly studied in the newborn auditory processing research?
|
Language comprehension. |
|
The primary focus is on foundational auditory abilities, such as beat perception, statistical learning, and rhythmic entrainment, which are precursors to more complex skills like language comprehension.
|
Information from the article "Beat processing in newborn infants cannot be explained by statistical learning based on transition probabilities"
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 11 |
What term is used to describe the appearance of scientific credibility used in the marketing of unproven cell-based therapies?
|
Tokens of scientific legitimacy |
|
The article highlights "tokens of scientific legitimacy" as a key tactic used to mislead consumers into believing in the credibility of unproven cell-based therapies, emphasizing the need for evidence-based approaches and ethical practices.
|
Information from the article "International Society for Cell & Gene Therapy Position Paper: Key considerations to support evidence-based cell and gene therapies and oppose marketing of unproven products"
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 12 |
According to the article, which of the following is NOT a recognized reporting mechanism for adverse effects from cell and gene therapies?
|
Consumer Protection Agencies |
|
Consumer Protection Agencies are not designed to handle medical adverse event reporting. Their focus is on addressing consumer rights and issues like fraud or unsafe products in the marketplace, not tracking medical product safety.
|
Information from the article "International Society for Cell & Gene Therapy Position Paper: Key considerations to support evidence-based cell and gene therapies and oppose marketing of unproven products"
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 13 |
What ethical consideration is primarily challenged by direct-to-consumer marketing of unproven cell and gene therapies?
|
Informed consent processes |
|
Direct-to-consumer marketing of unproven cell and gene therapies primarily challenges the informed consent process, which is a cornerstone of ethical medical practice. This is due to misleading information, lack of transparency, and pressure to consent.
|
Information from the article "International Society for Cell & Gene Therapy Position Paper: Key considerations to support evidence-based cell and gene therapies and oppose marketing of unproven products"
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 14 |
What key feature differentiates proven CGT products from unproven ones according to regulatory standards?
|
Pre-marketing authorization by regulatory bodies |
|
The key feature that differentiates proven cell and gene therapy (CGT) products from unproven ones is pre-marketing authorization by regulatory bodies. This ensures safety and efficacy, compliance with standards, and transparency in data.
|
Information from the article "International Society for Cell & Gene Therapy Position Paper: Key considerations to support evidence-based cell and gene therapies and oppose marketing of unproven products"
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 15 |
Which of the following is a risk associated with unproven CGT products highlighted in the article?
|
Potential for serious health risks |
|
The article emphasizes the potential for serious health risks as a critical concern associated with unproven CGT products, underscoring the importance of regulatory oversight and evidence-based practices.
|
Information from the article "International Society for Cell & Gene Therapy Position Paper: Key considerations to support evidence-based cell and gene therapies and oppose marketing of unproven products"
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 16 |
Which of the following is NOT a typical characteristic of unproven CGT products as discussed in the article?
|
Approval by major regulatory agencies |
|
Regulatory approval by major agencies, such as the FDA or EMA, is a hallmark of proven therapies. In contrast, unproven products often bypass these processes, relying heavily on direct-to-consumer marketing. This lack of regulatory scrutiny and rigorous evaluation makes regulatory approval an uncommon characteristic of unproven CGT products.
|
Information from the article "International Society for Cell & Gene Therapy Position Paper: Key considerations to support evidence-based cell and gene therapies and oppose marketing of unproven products"
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 17 |
How do regulatory bodies like the FDA and EMA ensure the safety of CGT products?
|
By requiring rigorous pre-marketing clinical trials |
|
Regulatory bodies like the FDA and EMA ensure the safety of CGT products by requiring rigorous pre-marketing clinical trials, which involve thorough testing and evaluation to protect patient health and safety.
|
Information from the article "International Society for Cell & Gene Therapy Position Paper: Key considerations to support evidence-based cell and gene therapies and oppose marketing of unproven products"
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 18 |
What is the primary goal of the ISCT's position on cell and gene therapies as mentioned in the article?
|
To support evidence-based products and oppose unproven ones |
|
The primary goal of the ISCT's position is to promote evidence-based cell and gene therapies (CGT) while actively opposing the marketing and use of unproven products.
|
Information from the article "International Society for Cell & Gene Therapy Position Paper: Key considerations to support evidence-based cell and gene therapies and oppose marketing of unproven products"
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 19 |
What is a potential consequence for patients using unproven CGT products?
|
Risk of serious adverse effects |
|
The primary consequence for patients using unproven CGT products is the risk of serious adverse effects, highlighting the importance of evidence-based practices and regulatory oversight to ensure patient safety.
|
Information from the article "International Society for Cell & Gene Therapy Position Paper: Key considerations to support evidence-based cell and gene therapies and oppose marketing of unproven products"
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 20 |
What role does the ISCT play in the context of cell and gene therapies?
|
It opposes the premature commercialization of unproven therapies. |
|
The International Society for Cell & Gene Therapy (ISCT) plays a vital role in promoting ethical practices and scientific rigor in developing cell and gene therapies (CGT). Its key functions include opposition to unproven therapies, advocacy for evidence-based practices, education, and awareness.
|
Information from the article "International Society for Cell & Gene Therapy Position Paper: Key considerations to support evidence-based cell and gene therapies and oppose marketing of unproven products"
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|